From development toward therapeutics, a collaborative effort on blood progenitors.
From development toward therapeutics, a collaborative effort on blood progenitors.
复制标题
从开发到治疗，血液祖细胞的协作努力。
DOI：
10.1016/j.stemcr.2021.05.010
复制
发表时间：
2021
影响因子：
5.9
通讯作者：
Zon,LeonardI
中科院分区：
文献类型：
--
作者：
Choudhuri,Avik;Han,Tianxiao;Zon,LeonardI
国家心肺和血液研究所祖细胞翻译联盟血液祖细胞会议于2020年11月5日以虚拟方式举办，共有20个研究小组的93名与会者。本次会议的目的是交流最新的发现，讨论目前的努力，并确定在造血干细胞和祖细胞研究和治疗发现领域的前景机会。
The National Heart, Lung, and Blood Institute Progenitor Cell Translational Consortium Blood Progenitor Meeting was hosted virtually on November 5, 2020, with 93 attendees across 20 research groups. The purpose of this meeting was to exchange recent findings, discuss current efforts, and identify prospective opportunities in the field of hematopoietic stem and progenitor cell research and therapeutic discovery.